EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

IFNIKB: a type I interferon database for antitumour immunity studies

Fubo Ma, Kang Li, Yangchao Yu, Lei Zhang, Liguo Zhang, Bing Li, Le Zhang iD

Database · 2026

DOI: 10.1093/database/baag053 ↗

At a glance

Journal article in Database, 2026. Written by Fubo Ma and 6 co-authors. Institution: College of Computer Science, Sichuan University, Chengdu, 610065, China. Major MEDLINE topics: Interferon Type I, Databases, Protein. 66 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China, National Science and Technology Major Project, Sichuan Science and Technology Program key project.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Type I interferon (IFN-I) is an important class of cytokines that can inhibit tumour progression through mechanisms such as immunomodulation of the tumour microenvironment or targeting cellular components. Although various endogenous and exogenous IFN-I therapeutic strategies have been developed, reports of immune cell dysfunction resulting from IFN-I signal enhancement indicate that optimal strategies have yet to be established. However, heterogeneous data of IFN-I are currently spread across multiple public databases and lack systematic integration, which poses challenges for knowledge acquisition and clinical research promotion. Herein, we develop the IFN-I Knowledge Base (IFNIKB), the first specific database for IFN-I. It integrates 26 273 literature articles on IFN-I antitumour immunity, 2202 clinical trial records, and data on 8372 genes and 7164 proteins across 654 species. Furthermore, we design an automated workflow for knowledge discovery from literature. Users can construct on-demand knowledge graphs to explore entities and relationships through interactive visualizations, temporal trends, and network topology analyses. Additionally, we provide tools for multiple sequence alignment, sequence identity computation, and phylogenetic analysis to interpret IFN-I from molecular perspectives. Therefore, researchers can employ IFNIKB to conveniently acquire knowledge, propose hypothesis, optimize experimental design, and identify potential clinical therapeutic targets. Database URL: http://www.combio-lezhang.online/IFNIKB/home

Subjects

MeSH terms (MEDLINE)

Interferon Type IDatabases, ProteinHumansAnimalsBiocurationPhylogeny

Substances

Interferon Type I

Authors and institutions

  • College of Computer Science, Sichuan University, Chengdu, 610065, China.
  • West China Biomedical Big Data Center, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Key Laboratory of Biomacromolecules (CAS), National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.

ORCID profiles: Le Zhang

Funding

  • National Natural Science Foundation of China
  • National Science and Technology Major Project
  • Sichuan Science and Technology Program key project

Cite

APA

Ma, F., Li, K., Yu, Y., Zhang, L., Zhang, L., Li, B., & Zhang, L. (2026). IFNIKB: a type I interferon database for antitumour immunity studies. Database. https://doi.org/10.1093/database/baag053

Vancouver

Ma F, Li K, Yu Y, Zhang L, Zhang L, Li B, et al. IFNIKB: a type I interferon database for antitumour immunity studies. Database. 2026. doi:10.1093/database/baag053

BibTeX
@article{Ma2026,
  author = {Ma, Fubo and Li, Kang and Yu, Yangchao and Zhang, Lei and Zhang, Liguo and Li, Bing and Zhang, Le},
  title = {IFNIKB: a type I interferon database for antitumour immunity studies},
  journal = {Database},
  year = {2026},
  doi = {10.1093/database/baag053}
}
Start for free →